Ascension Ventures is a private equity and venture capital firm based in London, United Kingdom, founded in 2012. It focuses on early-stage to growth investments in the United Kingdom, including SEIS and EIS eligible opportunities. The firm targets technology and media driven sectors such as digital media, creative industries, advertising technology, fintech, educational technology, health technology, and next generation platforms, as well as e-commerce, sustainability, energy, transport, and consumer goods. It supports seed to growth rounds and is open to co-investments with angels and other funds, aiming to exit investments in four to seven years. The firm emphasizes building practical partnerships with portfolio companies to foster scale and long-term value.
Neuronostics Ltd is a spin-out from the University of Exeter in the UK, dedicated to developing and commercializing innovative technology for assessing seizure susceptibility. The company has created a novel platform that focuses on diagnosing and prognosticating neurological conditions, specifically targeting epilepsy. Utilizing a patented seizure risk score derived from routine electroencephalogram (EEG) recordings, Neuronostics' technology aims to facilitate early diagnosis and prognosis of epilepsy. This advancement is designed to empower clinicians to enhance patient care and improve the quality of life for individuals living with this neurological condition.
Neurolutions
Venture Round in 2015
Founded in 2007, Neurolutions develops non-invasive brain-computer interface devices aimed at restoring functionality to individuals disabled by neurological injuries. Their technology uses electroencephalography (EEG) electrodes to interpret intended muscle movements, facilitating rehabilitation and maintaining range of motion.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.